Message from the President
This past year has been the most exciting in the history of Conquer Paralysis Now (CPN), formerly known as the Sam Schmidt Paralysis Foundation.
The sense of urgency is real. Although many important developments in spinal cord injury (SCI) research and treatment are underway, the fact is that tangible progress is slow in coming. CPN is bridging the gap between research and reality with the CPN Challenge Program—an innovative series of prize competitions designed to incentivize the most promising research opportunities and fast-track major breakthroughs that will improve functionality for people living with paralysis.
We are pleased to announce the winners of Stage 1, Round 1. With many novel ideas never getting off the ground due to a lack of initial data needed to win traditional research grants, CPN is awarding 10 individuals with $50,000 each and two teams $100,000 each for their unconventional, disruptive approaches.
The CPN Challenge was launched to find a cure for paralysis by driving the development of treatments for spinal cord injuries to help patients regain such everyday functions as standing, reaching and grasping, and bowel and bladder control. CPN’s Science Advisory Council selected this round’s grant recipients from a pool of 100 applicants representing 80 institutions and more than 25 countries.
The current climate is such that researchers are often unlikely to receive funding unless their idea shows great promise and precedent and they have the data to support their research. We are transforming the funding landscape and encouraging researchers to take risks, helping us accelerate progress toward finding a cure. We are motivated by the singular goal of finding a cure for paralysis, that is restoring important functions for those living with SCI, and believe we can meet this objective within the next decade or sooner through the innovative concepts and research fostered by the CPN Challenge.
Together with the money, we will also provide grant recipients access to relevant human capital as a valuable way of making the most effective use of their received funding. The mentorship program will focus on key areas including the FDA regulatory process, translation of ideas, manufacturing, and technology.
While the leading scientists we support are successful in competing for funding from the Federal government and other major and prestigious granting agencies, transformative philanthropy is what will fuel our race to the cure. For more information, please contact me at our office (609) 737-1919 or by email at email@example.com.